Bayesian Capital Management’s ChampionX CHX Stock Holding History

Bayesian Capital Management’s Portfolio CHX Stock Details CHX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-9,100	Closed	-$226K	–	569
2025 Q2	$226K	Buy	+9,100	New	+$229K	0.04%	437
2025 Q1	–	Sell	-30,722	Closed	-$835K	–	655
2024 Q4	$835K	Sell	30,722 -2,300	-7%	-$68.4K	0.1%	270
2024 Q3	$996K	Buy	+33,022	New	+$1.04M	0.12%	245
2024 Q2	–	Sell	-29,322	Closed	-$1.05M	–	786
2024 Q1	$1.05M	Buy	+29,322	New	+$877K	0.1%	277
2023 Q3	–	Sell	-10,421	Closed	-$323K	–	729
2023 Q2	$323K	Buy	+10,421	New	+$287K	0.03%	515

Other funds holding CHX

VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Bayesian Capital Management's CHX Position: Q3 2025 in Review

Bayesian Capital Management sold out of ChampionX (CHX) in Q3 2025, closing a stake of 9,100 shares — an estimated $226K sold.

Bayesian Capital Management first reported a position in CHX in Q2 2023 and held it in 5 quarters. The position peaked at $1.05M in Q1 2024. 3 funds tracked by Wall St. Rank hold CHX as of Q3 2025.

Bayesian Capital Management reported no remaining ChampionX position as of Q3 2025 after selling out during the quarter.
Bayesian Capital Management sold 9,100 ChampionX shares in Q3 2025, an estimated $226K.
Bayesian Capital Management first reported a position in ChampionX in Q2 2023 and held it in 5 quarters.
Bayesian Capital Management's ChampionX position peaked at $1.05M in Q1 2024.
3 funds tracked by Wall St. Rank held ChampionX as of Q3 2025.

Based on Bayesian Capital Management's 13F filing for Q3 2025, filed 14 Nov 2025.